West Pharmaceutical Services news
The WiseView Research desk's stories that name West Pharmaceutical Services, the latest headlines about it, and the trades members of Congress and company insiders have disclosed. The WST page →
- HeadlineWest Pharmaceutical (WST) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
- HeadlineWST Q3 Earnings Preview: Will HVP Strength Offset Vantage Weakness?
- HeadlineReasons to Add West Pharmaceutical Stock to Your Portfolio Now
- HeadlineWest Declares Quarterly Dividend
- HeadlineWest Pharmaceutical Stock Gains 36.1% YTD: What's Behind the Rally?
- HeadlineWest to Host Third-Quarter 2026 Conference Call
- HeadlineWest Pharma: Still A Buy, But Expectations Are Rising
- CongressLisa McClain bought $1,001 - $15,000 of WST
- CongressLisa McClain sold $1,001 - $15,000 of WST
- CongressRob Bresnahan sold $1,001 - $15,000 of WST
- CongressJared Moskowitz sold $1,001 - $15,000 of WST
- CongressJared Moskowitz sold $1,001 - $15,000 of WST
Headlines link to their publishers. Members of Congress disclose ranges, not exact amounts, and may file weeks after the trade; insider filings are open-market purchases and sales from SEC Form 4. For information only, not investment advice.